Background {#Sec1}
==========

Invasive angiography is the reference test for the diagnosis of CAD. However, the relationship between the angiographic stenosis severity and the coronary blood flow is complex. The visual assessment of stenosis severity is subjective and correlates poorly with physiological significance \[[@CR1]\]. Unfortunately, coronary angiography has many pitfalls and limitations that may impair the judgment of stenosis severity and then affect decision-making regarding intervention. The limitations of coronary angiography include the interpretation is highly subjective (inter- and intra-observer variability) \[[@CR2]--[@CR4]\], comparing to normal reference segment can be fallacious in diffuse disease, the eccentric lesions have a varying appearance of severity in different views \[[@CR5]\], and several artifacts can give a false impression about severity. In addition to all of the previous limitations that make conventional coronary angiography correlates poorly with physiological significance, assessment of intermediate or borderline coronary lesions is another common challenge in routine practice. The physiological assessment of coronary lesions has become a cornerstone practice in the current clinical cardiology guidelines. Myocardial perfusion imaging by single-photon emission tomography (MPI--SPECT) is used for a long time to detect reversible ischemia, quantify defect sizes and help clinical decisions of interventions. It has been even used for early validation of invasive physiological assessment by fractional flow reserve (FFR). Despite this fact, the patient outcome studies performed on the role of invasive physiological assessment by FFR created a prestigious position and enlightened a hot spot on FFR use for functional assessment of coronary lesions, and so FFR is now considered the gold standard test for this purpose. However, fractional flow reserve (FFR) is considered a relatively expensive test, especially with limited resources in our country, and also implies the use of pharmacological hyperemic agents (e.g., adenosine) which are relatively not easily available in our country. The development of Instantaneous wave-free Ratio (IFR) as a relatively new invasive method for physiological assessment of coronary lesions without the use of pharmacologic hyperemic agents has solved the problem partially but is still considered a relatively expensive test with our limited resources. On the other hand, myocardial perfusion imaging by single-photon emission tomography (MPI-SPECT) is a non-invasive, relatively non-expensive test and is well supported in the national health insurance systems unlike the FFR and IFR which are much less supported by the insurance programs and so their use is usually limited even when needed for decision-making.

Aim of the work {#Sec2}
===============

The aim of this work was to compare the myocardial perfusion imaging by single-photon emission tomography (MPI-SPECT) as a non-invasive, relatively non-expensive test versus the instantaneous wave-free ratio (IFR) for the assessment of functional significance of the intermediate coronary artery lesions in the view of results of fractional flow reserve (FFR) which is considered the gold standard reference test.

Methods {#Sec3}
=======

This study prospectively recruited 50 ischemic heart disease patients presented to the cardiology department with intermediate (40--70%) lesions in coronary arteries to compare the results of single-photon emission tomography myocardial perfusion imaging (MPI-SPECT) versus instantaneous wave-free ratio (IFR) in the view of results of fractional flow reserve (FFR) as a gold standard reference.

The protocol was approved by the committee of the medical ethics of the cardiology department in March 2016 and informed written consent was obtained from all the patients. The pre-procedural assessment was done in the cardiology outpatient clinic.

Inclusion criteria:

Patients with angiographically borderline coronary artery stenosis (40--70%) in a single coronary artery were assessed by at least two expert operators. The following patients were excluded from our study:

I.Patients with certain limitations to FFR: A.Acute coronary syndrome: STEMI.Non-STE ACS. B.Patients with marked left ventricular hypertrophy: as microvascular abnormalities may be present and impair the results of FFR \[[@CR1]\].C.Patients with tandem lesions: FFR pullback has limited value for assessment of tandem successive coronary lesions \[[@CR6]\]. II.Contraindications to stress---Tc-99 MPI: \[[@CR7]\] Iodine 131 treatment within the last 3 months.Indium 111 or gallium 67 scan within the last month.Tc-99 imaging within 2 days.Pregnant ladies.Congestive heart failure.Severe hypertension (blood pressure \> 200/110 mmHg).Uncontrolled cardiac arrhythmias (causing symptoms or hemodynamic compromise).Severe valvular lesions.Acute pulmonary embolism.Other acute cardiac conditions (myocarditis, pericarditis, or aortic dissection.Significant pulmonary hypertension. III.Conditions that may cause a controversial interpretation of SPECT MPI:

Previous myocardial infarction and Multi-vessel disease. IV.Clinically unstable patients for any reason (e.g., severe infections).

The patients were subjected to the following:

Informed consent: According to the World Medical Association (WMA) Declaration of Helsinki 2013 \[[@CR8]\]. For each patient, history was taken and physical examination was performed. The electrocardiographic recording was done to each patient to detect any baseline abnormalities. All the patients were subjected to detailed conventional M-mode and 2D transthoracic echocardiographic examination and Doppler study using standard parasternal and apical views following the recommendations of the European Association of Cardiovascular Imaging \[[@CR9]\] using an imaging system equipped with a 2--4 MHz transducer, to assess left ventricular dimensions, posterior wall (PWT), septal wall thickness(SWT), fractional shortening (FS), and ejection fraction (EF). All the patients underwent stress/rest Tc99m SestaMIBI SPECT 2-day protocol to study myocardial perfusion \[[@CR7]\] using Siemens Symbia-E dual head system- Syngo MI workplace 2011-Emory Cardiac toolbox software system.

Myocardial perfusion image (MPI) protocol: \[[@CR7], [@CR10]\]Two-day protocol, stress, and rest Tc99m sestaMIBI myocardial perfusion SPECT was performed.Patients were exercised on a treadmill according to the standard Bruce protocol \[[@CR7]\].Patients with contraindications for exercise test underwent pharmacologic stress test (Dobutamine stress test).Technetium-99m Sestamibi 20 mCi was injected at peak exercise. Then, the patient was instructed to eat a fatty meal to decrease hepatic activity during imaging.After 30--60 min, imaging acquisition started. Imaging was in the supine position.On the second day, patients were re-injected by 20 mCi Tc99m sestaMIBI and re-imaged after 30--60 min with the same protocol. The image processing and reconstruction were performed according to the American Society of Nuclear Cardiology guidelines \[[@CR7], [@CR10]\].Image analysis was performed using a previously validated automated program that determines the extent and severity of LV perfusion defect size and the extent of reversible (ischemia) or fixed (scar) resting hypoperfusion and LVEF.SPECT MPI results were considered positive when the defect size ≥ 10% in the territory of interest. I.Instantaneous wave-free ratio (IFR) and Fractional Flow Reserve (FFR): \[[@CR1], [@CR6], [@CR11]\] Each patient underwent IFR and FFR measurements, the following technique was applied: Philips Volcano system was used for IFR & FFR measurements using prime-prestige pressure wires.Routine preparation:Patients were instructed to stop caffeine intake 24 h before the procedure as caffeine is considered as adenosine receptor antagonist that may interfere with adenosine-induced hyperemia and affects FFR results \[[@CR12]\]. No anesthesia was required.Access: routine trans-femoral or trans-radial approach for cardiac catheterization was applied.Diagnostic coronary angiography was done with localization of the site of stenosis of interest.Calibration of pressure systems: the pressure lines were flushed with saline. Then, the "zero- reference" was recorded.

The sensor was then positioned 2 mm distal to the tip of the guiding catheter and we flushed the guiding catheter using saline. At that site, both pressures were identical. If the two pressures were not equal, the measured pressures had to be equalized electronically, using that function of the console. If there was ostial stenosis, this should be performed with the pressure sensor positioned in the aorta. The sensor was then manipulated in the distal part of the artery. In any case, the sensor was placed 3 cm distal to the stenosis to be assessed, a distance where the post-stenotic laminar flow is restored. The pressure transducer was located approximately 3 cm proximal to the distal tip of the wire and it could be seen by fluoroscopy. Instantaneous wave-free ratio (IFR) was calculated in a computerized manner independent of any induced hyperemia. An IFR value lower than 0.89 was considered positive indicating hemodynamically significant stenosis and IFR value higher than 0.89 was considered negative indicating stenosis that is not hemodynamically significant \[[@CR1], [@CR12]\].To measure fractional flow reserve (FFR); once the transducer was distal to the stenosis, a hyperemic stimulus was administered by injection through the guide catheter, and the FFR is monitored for a significant change.Intracoronary adenosine was used: 100 μg bolus in the right coronary artery or 200 μg bolus in the left coronary artery \[[@CR13]\]. Intracoronary adenosine was a well-accepted alternative to intravenous adenosine to achieve maximal hyperemia for FFR measurements \[121\]. Using intracoronary adenosine was used to overcome the higher costs and the relative non-availability of adenosine in Egypt.The mean arterial pressures from the pressure wire transducer and from the guide catheter were then used to calculate FFR \[[@CR1], [@CR13]\].In the case of adenosine-induced hyperemia: an FFR value lower than 0.8 was considered positive indicating significant stenosis and FFR value higher than 0.8 was considered negative indicating stenosis that was not hemodynamically significant \[[@CR1], [@CR6]\].

Statistical analysis {#Sec4}
====================

Analysis of the data was performed using SPSS v. 23 (Statistical Package for Social Science) for Windows. The description of the variables was presented as follows: The description of quantitative variables was in the form of mean, standard deviation (SD), median, and range (min-max).The description of qualitative variables was in the form of numbers (no.) and percent (%).The data were explored for normality using Shapiro/Kolomogrov tests of normality.Kappa agreement was done to test the agreement between the MPI and the IFR with the gold standard FFR.Pearson correlation was conducted to test the correlation between the MPI and the IFR with the gold standard FFRKappa and correlation coefficient *r* was considered mild till 0.3, moderate till 0.6 and strong for more than 0.6.ROC curve was used to assess the cut-off points of MPI and IFR at which we can find the best prediction of positive cases by FFR.

The results were assessed in the form of *P* value that was classified into: Non-significant when *P* value \> 0.05Significant when *P* value ≤ 0.05Highly significant when *P* value ≤ 0.001

Results {#Sec5}
=======

The study was conducted in the Cardiology Department, in the period between January 2017 and June 2019. It included 50 patients with stable coronary artery disease and intermediate coronary artery lesions, they underwent physiological evaluation by stress/rest myocardial perfusion imaging using single-photon emission tomography (SPECT-MPI) followed by an invasive physiological assessment by instantaneous wave-free ratio (IFR) and fractional flow reserve (FFR). Finally, the results of both SPECT MPI and IFR were compared to FFR as a gold standard reference Table [1](#Tab1){ref-type="table"} shows Age and sex distribution of the studied patients, Table [2](#Tab2){ref-type="table"} shows Distribution of co-morbidities of medical importance among the studied patients, Table [3](#Tab3){ref-type="table"} shows Family history and special habits of medical importance among the studied patients, Table [4](#Tab4){ref-type="table"} shows Description of body morphology of medical importance among the studied patients, Table [5](#Tab5){ref-type="table"} shows Coronary lesions severity of the affected vessels in the studied patients, Table [6](#Tab6){ref-type="table"} shows Distribution of the target vessel among the studied patients, Table [7](#Tab7){ref-type="table"} shows Description of the spectroscopy MPI defect size of the affected vessels in the studied patients, Table [8](#Tab8){ref-type="table"} shows Description of the spectroscopy IFR of the affected vessels in the studied patients and Table [9](#Tab9){ref-type="table"} shows Description of the spectroscopy FFR of the affected vessels in the studied patients. Table 1Age and sex distribution of the studied patientsParametersValuesAge Mean ±SD55.28 ±8.6 Range(min-max)(34-68) Median56Sex no. (%): Males36(72%) Females14(28%)Scale data were presented as mean ± SD and categorical data were presented as number (%) Table 2Distribution of co-morbidities of medical importance among the studied patientsCo-morbiditiesNumber\
*N* = 50Percent\
100%HTN Positive3264.0 Negative1836.0DM Positive2652.0 Negative2448.0Dyslipidemia Positive4080.0 Negative1020.0Data were presented as number and percen Table 3Family history and special habits of medical importance among the studied patientsco-morbiditiesNumber\
N=25Percent\
100%Family history Positive3264.0 Negative1836.0Smoking Smokers2652.0 Non-smokers2448.0Data were presented as number and percent Table 4Description of body morphology of medical importance among the studied patientsParametersValuesWeight Mean ± SD86.6 ± 17.9 Range(min-max)(55--130) Median85Height Mean ± SD1.69 ± 0.63 Range(min-max)(1.6--1.85) Median1.7BMI Mean ±SD30.1 ± 6.2 Range(min-max)(20.2--46.6) Median29.4Scale data were presented as mean ± SD Table 5Coronary lesions severity of the affected vessels in the studied patientsSizeValuesMean ± SD58.4 ± 8Range(min-max)(50--70)Median60Scale data were presented as mean ± SD Table 6Distribution of the target vessel among the studied patientsThe target vesselNumber (%)LAD32 (64%)LCX10 (20%)RCA8 (16%) Table 7Description of the spectroscopy MPI defect size of the affected vessels in the studied patientsParametersValuesDefect size of only positive MPI: Mean ± SD15.6 ± 4.5 Range (min-max)(10--22) Median14MPI results no. (%): Positive20(40) Negative30(60)Scale data were presented as mean ± SD and categorical data were presented as number (%) Table 8Description of the spectroscopy IFR of the affected vessels in the studied patientsParametersValuesIFR value Mean ± SD0.89 ± 0.094 Range (min-max)(0.65--1.05) Median0.92IFR results no. (%): Positive20(40) Negative30(60)Scale data were presented as mean ±SD & categorical data were presented as number (%) Table 9Description of the spectroscopy FFR of the affected vessels in the studied patientsParametersValuesFFR value Mean ± SD0.796 ± 0.1007 Range(min-max)(0.60--0.96) Median0.83FFR results no. (%): Positive22(44) Negative28(56)Scale data were presented as mean ± SD and categorical data were presented as number (%)

Table [10](#Tab10){ref-type="table"} demonstrates that there was a highly statistically significant (*P* value \< 0.001) negative strong correlation (*r* = − 0.7) between FFR and MPI. There was a highly statistically significant (*P* value \< 0.001) positive strong correlation (*r* = 0.947) between FFR and IFR. Table 10Correlation between the FFR, MPI, and IFR among the studied patientsFFR value\
(Cut-off = 0.80)SPECT-MPIIFR value\
(Cut-off = 0.89)Pearson correlation− 0.7040.947*P* value\< 0.001\< 0.001*N*2525

Table [11](#Tab11){ref-type="table"} shows that there was a strong (kappa = 0.754) significant (*P* value \< 0.001) agreement between the MPI results and FFR results and the overall agreement was 88%. The sensitivity of the MPI was 81.8%, the specificity was 92.9%, the positive predictive value was 90%, the negative predictive value was 86.7%, the positive likelihood ratio was 11.45, and the negative likelihood ratio was 0.20. Table 11Agreement between the MPI results and the FFR results in the studied patientsSPECT MPI resultFFR resultTotal+ve−ve+ve1822081.8%7.1%40.0%−ve4263018.2%92.9%60.0%Total222850100.0%100.0%100.0%*P* value\< 0.001\*\*Kappa Agreement0.754Data were presented as number and percent

Table [12](#Tab12){ref-type="table"} shows that there was a strong (kappa = 0.918) significant (*P* value \< 0.001) agreement between the IFR results and FFR results and the overall agreement was 96%. The sensitivity of the IFR was 90.9%, the specificity was 100%, the positive predictive value was 100 %, the negative predictive value was 93.3%, and the negative likelihood ratio was 0.09 Table [13](#Tab13){ref-type="table"} shows ROC curve results for the prediction of positive FFR cases by using the MPI and the IFR and Table [14](#Tab14){ref-type="table"} shows Summary of results of SPECT - MPI versus IFR side by side Figure [1](#Fig1){ref-type="fig"} shows ROC curve for the prediction of positive FFR cases by using the MPI and the IFR. Table 12Agreement between the IFR results and the FFR results in the studied patientsIFR resultFFR resultTotal+ve−ve+ve2002090.9%0%40.0%−ve228309.1%100%60.0%Total222850100.0%100.0%100.0%*P* value\< 0.001Kappa Agreement0.918Data were presented as number and percentN.B. the positive likelihood ratio was not calculated as the specificity was 100% and the PLR is calculated from the following equation: sensitivity/1−specificity = 90.9/1 − 1 = cannot be calculated Table 13ROC curve results for the prediction of positive FFR cases by using the MPI and the IFRTest result variable(s)Cut-offSensitivitySpecificityThe area under the curve95% confidence intervalLower boundUpper boundSPECT_MPI defect size581.8%92.9%0.8990.7541.000IFR value cut-off0.890.8590.9%100%1.0000.9501.000 Table 14Summary of results of SPECT-MPI versus IFR side by sideSPECT-MPIIFRNature of the testNon-invasive imagingInvasivePearson correlation to FFRStrong negative correlation(− 0.704)Strong positive correlation(0.947)Kappa agreement to FFR0.7540.918Overall agreement to FFR88%96%Sensitivity81.8%90.9%Specificity92.9%100%Positive predictive value (PPV)90%100%Negative predictive value (NPV)86.7%93.3%Positive likelihood ratio (PLR)11.45Cannot be calculatedNegative likelihood ratio (NLR)0.200.09Area under ROC curve0.8991.000Expected cut-off by ROC curveDefect size \> 5%\> 0.85 Fig. 1ROC curve for the prediction of positive FFR cases by using the MPI and the IFR

Discussion {#Sec6}
==========

Myocardial perfusion imaging by single-photon emission tomography (MPI SPECT) was shown to have high overall sensitivity and specificity estimated at 81.8% and 92.9%, respectively, as well as high positive predictive value (PPV) and negative predictive value (NPV) estimated as 90% and 86.7% respectively. Actually, this concordance between MPI SPECT and FFR results can be already expected and understood from the early validation studies on FFR itself that used MPI SPECT to assess the validity of FFR. In one study; I. Erhard, J. Rieber et al. \[[@CR14]\] SPECT MPI and dobutamine stress Echocardiography were used as reference tests to evaluate FFR and by performing ROC analysis, the best cut-off value (highest sum of sensitivity and specificity) was found at 0.75. At this cut-off value using both non-invasive tests as a reference method, sensitivity and specificity were 83% and 77%. Another study, Caymaz O, Fak A et al. \[[@CR15]\] prospectively evaluated 40 lesions using a 0.014 in. pressure wire during elective coronary angiography and compared the findings with those of myocardial perfusion 201 Thallium; the study concluded that FFRmyo seems to accurately predict the presence of ischemia on SPECT 201Tl in patients with Stable CAD, while QCA does not reliably assess the physiologic impact of the same lesions. Also, our results are consistent with some small previous studies that used the FFR as the gold standard test. In one study, Morteza Safi et al. \[[@CR16]\] published at the Egyptian Heart Journal in 2016, conducted on 45 patients and concluded that there was a significant concordance between FFR and myocardial perfusion imaging for assessment of ischemia, for LAD territory involvement, myocardial perfusion imaging had a sensitivity, specificity, PPV, NPV, and accuracy of nearly 67%, 71%, 31%, 92%, and 70%; for LCX territory involvement, myocardial perfusion imaging had a sensitivity, specificity, PPV, NPV, and accuracy of nearly 100%, 60%, 33%, 100%, and 67% and for RCA territory involvement, myocardial perfusion imaging SPECT had a sensitivity, specificity, PPV, NPV, and accuracy of 100%, 60%, 20%, 100%, and 70%, respectively. In the study by Ilgin Sahiner et al. \[[@CR17]\], the Quantitative MPI SPECT analysis compared to FFR has overall sensitivity and specificity of 85% and 84%, respectively, and it was superior to visual analysis.

Tao Zhoua et al. \[[@CR18]\] reviewed 13 manuscripts. The pooled data at the vessel level was a sensitivity of 66% (95% CI, 57--74%) and specificity of 81% (95% CI, 70--89%).

In another meta-analysis, Ibrahim Danad et al. \[[@CR19]\] evaluated MPI SPECT among other non-invasive tests to determine the diagnostic performance of these tests when compared to the gold standard FFR. At the patient level, 110 patients were involved, the summary sensitivity and specificity were 70% (59--80%) and 78% (68--87%) for MPI SPECT; and the positive and negative likelihood ratios were 3.4 (1.04--11.08) and 0.4 (0.19--0.83). At the vessel-level, 470 vessels were involved, pooled sensitivity was 57% (49--64%) and specificity was 75% (69--80%); the positive and negative likelihood ratios were 2.34 (1.61--3.42) and 0.55 (0.44--0.69). Neng Dai et al. \[[@CR20]\] evaluated MPI SPECT among other non-invasive tests to determine the diagnostic performance of these tests when compared to the FFR. The overall sensitivity and specificity were 78% (71--84%) and 79% (70--87%) while the positive and negative likelihood ratios were 3.76 (2.52--5.63) and 0.28 (0.21--0.37). Juhani Knuuti et al. \[[@CR21]\] published MPI SPECT overall sensitivity and specificity were 73% (62--82%) and 83% (71--90%) while the positive and negative likelihood ratios were 4.21 (2.62--6.76) and 0.33 (0.24--0.46).

On the other hand, some studies showed poor concordance between MPI SPECT and FFR especially in the patients with multi-vessel disease which was a more challenging situation to MPI SPECT evaluation due to the fact that MPI SPECT actually assesses the relative blood flow differences among vascular territories and so the possibility of balanced ischemia in the presence of more than one vessel disease may be an obstacle for accurate assessment. For example, in Narbeh Melikian et al. study \[[@CR22]\] more than 60 patients (nearly 200 vascular territories) with angiographic more than one vessel coronary disease were prospectively scheduled to undergo rest/stress myocardial perfusion imaging and FFR in each vessel; in nearly 42% of patients, MPI and FFR detected identical ischemic territories, in 36%, MPI underestimated and in 22% overestimated the number of ischemic territories in comparison with FFR. There was no an accurate concordance between the ability of the two techniques to detect significant ischemia. On a per-patient basis, there was no accurate concordance between the ability of the two techniques to detect significant ischemia. In comparison with the FFR, the sensitivity, specificity, PPV, and NPV of MPI being able to detect myocardial ischemia was 76%, 38%, 66%, and 50%, respectively. Also on a per-vessel basis, there was no accurate concordance between the MPI and the FFR to detect significant ischemia. Tao Zhou et al. \[[@CR18]\] stated that multi-vessel disease leads to the limitation of the myocardial perfusion imaging to assess the functional significance of coronary artery disease in patients with multi-vessel and left main coronary artery disease. In our small study, we excluded multivessel disease to avoid this dilemma especially with the limited resources that served the study on a relatively small sample of patients and we hope that the patients with multi-vessel and left main disease will be targeted in larger studies.

The instantaneous wave-free ratio (IFR) was shown to have sensitivity and specificity estimated as 90.9% and 100%, respectively, as well as positive predictive value (PPV) and negative predictive value (NPV) estimated as 100% and 93.3% respectively. Actually, this concordance between IFR and FFR results can be already expected and understood from the validation studies on IFR which compared both IFR and FFR against different other third-party tests and showed a great concordance between the two methods. In one study: the CLARIFY \[[@CR23]\]. In nearly 50 vessels, the IFR, FFR, and HSR (hyperemic stenosis resistance) were compared. The IFR and FFR had an equally good diagnostic agreement with HSR.

In another study; Hwang D, Jeon K-H, et al. \[[@CR24]\] included more than 100 consecutive patients with LAD stenosis who underwent both PET scan and invasive physiological assessment then optimal cut-off values of FFR, IFR, and resting Pd/Pa were assessed using PET-derived coronary flow reserve (CFR) and relative flow reserve (RFR) as references. The overall diagnostic accuracy of FFR, IFR, and resting Pd/Pa was not different for CFR \< 2.0 (nearly FFR 70%, iFR 74%, and resting Pd/Pa 70%) and RFR \< 0.75 (nearly FFR 74%, IFR 71%, and resting Pd/Pa 75%). Also, this concordance continued in large patient outcome trials conducted on both tests especially DEFINE-FLAIR \[[@CR25]\] and IFR SWEDEHEART \[[@CR26]\].

There are also some small studies were similar to our study design and compared IFR results directly to FFR results as a gold standard reference test.

In one study, Tobias Härle et al. \[[@CR27]\] assessed the accuracy of the IFR prospectively in more than 100 patients with borderline coronary lesions; the IFR correlated strongly with the FFR (*r*~s~ = 0.81; *P* \< 0.0001). ROC analysis showed an area under the curve (AUC) equals 0.9106, suggesting the high reliability of the IFR as an accurate diagnostic test. The IFR-only technique with a treatment cut-point ≤ 0.89 revealed a diagnostic agreement with the FFR-only technique strategy in more than 120 lesions (nearly 83%) with a sensitivity of nearly 80%, a specificity of 86%. In another study, Alfredo Fede et al. \[[@CR28]\] included more than 50 patients with borderline lesions and there was close agreement between the FFR and the IFR (*R* = 0.83, *P* \< 0.0001). Deep Chandh Raja et al. \[[@CR29]\] found that IFR correlated with FFR in all the subgroups and across all the vessels, without any influence for the heart rate or blood pressure on the correlation with FFR.

Also, there are some meta-analysis studies that addressed this point and clarified this concordance.

In one meta-analysis, Salvatore De Rosa et al. \[[@CR30]\] evaluated nearly 6000 lesions. There was a significant correlation between the FFR and IFR of 0.798 (0.78--0.82; *P* \< 0.001). Also, they compared IFR and FFR to a third independent reference standard that was invasive coronary flow reserve, non-invasive coronary flow reserve, hyperemic stenosis resistance, a combined reference standard of myocardial perfusion scintigraphy, and hyperemic stenosis resistance index or positron emission tomography perfusion imaging. There were no significant differences between IFR and FFR, both in terms of diagnostic accuracy, measured as the area under the ROC curve and in terms of the diagnostic agreement to the third comparator used in these studies.

In another meta-analysis Rohit Maini et al. \[[@CR31]\] nearly 6000 lesions were evaluated. Pooled diagnostic accuracy estimates of IFR versus FFR were: sensitivity 0.78 (95% CI, 0.76--0.79), specificity 0.83 (0.81--0.84), the positive likelihood ratio was 4.54, negative likelihood ratio 0.28 (0.24--0.32), diagnostic odds ratio 17.38 (14.16--21.34), area under the ROC curve was 0.87, and the overall diagnostic accuracy was 0.81.

Limitations of the study {#Sec7}
------------------------

Despite the encouraging results presented in our small study, there were significant limitations including the small sample size and the exclusion of some types of patients that may be candidates for evaluation as patients with previous myocardial infarction and patients with multi-vessel disease.

Conclusions {#Sec8}
===========

The myocardial perfusion imaging by single-photon emission tomography (MPI SPECT) and instantaneous wave-free ratio (IFR) techniques showed significant concordance with fractional flow reserve (FFR) which is the gold standard reference test for physiological assessment of coronary lesions regardless of the type of diseased coronary artery. In this context, both MPI SPECT and IFR showed high sensitivity, specificity, NPV, and PPV compared with FFR. Therefore, the instantaneous wave-free ratio (IFR) may be a valid alternative to fractional flow reserve to assess the functional significance of intermediate coronary lesions without using agents to induce maximal hyperemia. More importantly, this study may encourage the use of myocardial perfusion imaging by single-photon emission tomography (MPI SPECT) as an alternative, non-invasive, relatively non-expensive test for the evaluation of the physiological significance of intermediate coronary lesions.

We hope and recommend that this study will be a nucleus for further larger studies in the future that may present more solid evidence and target special patient populations excluded from this study as patients with previous myocardial infarction and patients with multi-vessel disease.
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